9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN2749 | (2-Aminoethyl)phosphinic acid | Others | |
The specific growth rates of C. raciborskii cells in media treated with β-glycerol phosphate, d-glucose-6-phosphate, and (2-aminoethyl)phosphinic acid are significantly higher than those of cells grown in phosphorus free... | |||
T15391 | Glufosinate ammonium | Others | |
Glufosinate ammonium is a phosphinic acid analog of glutamic acid and an herbicide with neurotoxic activity. It is converted by plant cells into PT (L-phosphinothricin). | |||
T20416 | Phenylphosphinic acid | NSC 2670,NSC2670,NSC-2670 | Others |
Phenylphosphinic acid (NSC-2670) is an additive used with Noyori's catalyst and improves the flame retardancy of poly(lactic acid). Phenylphosphinic acid can be used for oxidation of sulfides to sulfones. | |||
T38438 | 3-Aminopropylphosphinic acid | 3-APPA,CGA147823,CGP27492 | |
3-Aminopropylphosphinic acid (3-APPA) is a phosphonic analog of gamma-aminobutyric acid (GABA). It acts as a potent and selective agonist of the GABA B receptor. | |||
T1489 | Fosinopril sodium | SQ28555 | RAAS |
Fosinopril sodium is a phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat. | |||
T20518 | Fosinoprilat | SQ-27,519,Fosinopril diacid,SQ 27,519,SQ27,519 | |
Fosinoprilat, an active phosphinic acid metabolite of prodrug fosenopril, is activated by esterases in vivo. Fosinoprilat binds zinc with phosphinic acid group. | |||
T20520 | Fosinopril | ||
Fosinopril, a phosphinic acid-containing angiotensin-converting enzyme inhibitor, is effective in hypertension treatment. Fosinopril is a prodrug that is converted to its active metabolite fosinoprilat. | |||
T15391L | Glufosinate | Others | |
Glufosinate, a phosphinic acid analog of glutamic acid, is a herbicide that is converted by plant cells into PT (L-phosphinothricin). It has neurotoxic activity. | |||
T69998 | DG046 | ||
DG046 is a novel potent phosphinic pseudopeptide ERAP1 inhibitor, binding in the ERAP1 active site, being stabilized by an unusual extensive network of π-stacking interactions |